By enhancing the activity of NF-kB and production of cytokines (including anti-apoptotic cytokines IL-6, IL-1a, and GM-CSF), TME would protect tumor cells from DNA damage caused by antitumor drugs such as doxorubicin35. The gene discussed is CSF2; the disease is neoplasm.